source
- Patient with EGFR-mutated NSCLC develops brain metastases after first-line EGFR inhibitor and chemotherapyDr. Sands presented a case of a patient with metastatic non-small cell lung cancer that carries an EGFR mutation. The patient was treated with a first-line regimen that combined an EGFR tyrosine k…
- Celcuity reports positive Phase 3 results for gedatolisib in PIK3CA-mutant breast cancerOn May 4, 2026 Celcuity announced that its experimental drug gedatolisib achieved success in two treatment regimens for patients whose tumors carry PIK3CA mutations, according to data from its ongo…